Should You Buy Harte Hanks, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Harte Hanks, Inc. (HHS) carries a solid Quality of Company rating of 6.4/10. Trading at $2.45, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 9 of 12 CirclFi valuation models project upside for Harte Hanks, Inc. (HHS) at $2.45 — the model consensus leans bullish, with a Quality Score of 6.4/10 and Value-Trap risk of 14/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
Investment Thesis
The Bull Case
Target: $13.81 (+463.5% upside)
- According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $2.45 and the composite fair value of $5.27 implies +115.2% upside potential.
- According to the CirclFi Deep Alpha Valuation Engine, the Earnings Power Value (EPV) model targets a fair value of $13.81 (+463.5%), anchoring the bull case with a methodology that strips out growth assumptions to value sustainable earnings alone.
The Bear Case
Target: $0.68 (-72.4%)
- According to the CirclFi Deep Alpha Valuation Engine, the First Chicago model sees the stock as overvalued with a fair value of $0.68 (-72.4%), suggesting that the market price embeds overly optimistic growth assumptions.
- According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +535.9% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.
The Bottom Line
Harte Hanks, Inc. at $2.45 presents what our engine identifies as a high-conviction opportunity: 9 of 12 models see upside, quality stands at 6.4/10, and the composite fair value of $5.27 implies +115.2% return potential. Investors should verify this thesis against their own risk parameters and time horizon.
These are quantitative model outputs, not investment recommendations. Harte Hanks, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
Frequently Asked Questions
Should I buy HHS stock right now?
Based on CirclFi's multi-model analysis, 9 of 12 models see upside for HHS at $2.45. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 6.4/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Harte Hanks, Inc.?
Key risks include: wide model disagreement (1943% spread), signaling high uncertainty; general market and sector-specific risks affecting Services-Direct Mail Advertising Services companies. Always diversify and consult a financial advisor.
How does HHS compare to its competitors?
HHS operates in the Services-Direct Mail Advertising Services sector. Visit our Services-Direct Mail Advertising Services rankings page for a full peer comparison.
Is HHS a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. HHS's Quality Score of 6.4/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy HHS at?
CirclFi does not provide target buy prices or price alerts. However, our 12 active models produce fair value estimates ranging from $0.68 to $13.81. At $2.45, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for HHS.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →